ALPA — Stock Film
STOCK FILMSCENE 1/11ALPA · $9.80
Stock Expert AI presents
ALPA
Alpha Healthcare Acquisition Corp. III
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Alpha Healthcare Acquisition Corp. III. A quick introduction.

On the stock market since 2021, it operates in the world of money and finance. Now — the numbers.

on the stock market since 2021
$193.7M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $5.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
The sales picture, year by year.

Red columns mark years that ended in a loss.

$0
2021
$0
2022
$0
2024
$1.9M
2025
In the vault right now:
$0
DEBT: $310K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

What executives did with their own stock over the last 12 months:
117 buy4 sell

Executives buying with their own money is usually read as confidence in the company’s future.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Heavy investment in the future10/10
WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 11% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $1.9M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Executives are buying their own stock

Over the last 12 months, company executives reported 117 buys and 4 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $6.9M against $1.9M in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, ALPA sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ALPA is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film